TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
AARD

Aardvark Therapeutics, Inc.

Healthcare · Biotechnology

5.00$ -5.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Aardvark Therapeutics, Inc. (AARD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 81 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AARD
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 11 – 87 84 78 157 147 133 117 99 81
– 10 – 87 83 74 155 145 129 112 94 81
– 9.7 – 86 82 62 27 26 39 47 62 74
– 10.0 10.0 86 82 74 151 142 126 110 91 74
– 45 -9.1 130 130 132 6.3 11 11 11 12 6.7
– 1.4 – 2.7 2.6 4.9 6.0 10 11 11 12 6.4
– 0.1 – 0.1 0.3 0.3 0.4 0.4 0.4 0.4 0.3 0.4
– 1.0 – 1.2 0.7 2.3 2.6 5.1 4.4 2.1 4.5 2.1
– -35 9.1 -42 -46 -55 151 137 122 107 87 75
– -38 – -45 -50 -58 -68 -82 -98 -116 -138 -152
21 21 21 21 21 22 22 22 22 22 22 22

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?